Google launches AI to help find genetic causes of disease

A clean, bright laboratory scene with a large translucent DNA double helix at center, subtle glowing mutation markers along the strand, soft bokeh tissue cell imagery behind, the Google multicolor G and the DeepMind swirl logo floating as polished 3D emblems near the helix, cool white and sky-blue lighting with vivid red, green, yellow accents, medium close-up framing, high contrast and glossy reflections

Google DeepMind released a new AI system called AlphaGenome to help researchers find the genetic causes of disease. The tool predicts how mutations change gene activity in different body tissues. It can analyze up to 1 million letters of DNA code at once.

How AlphaGenome Works

The human genome contains 3 billion pairs of letters. Only 2% of these letters tell cells how to make proteins. The remaining 98% controls when and where genes turn on or off. AlphaGenome focuses on this larger portion.

According to The Guardian, DeepMind trained the system on public databases of human and mouse genetics. The AI learned connections between mutations in specific tissues and their effects on gene regulation.

Most common diseases that run in families have been linked to mutations affecting gene control. These include heart disease, autoimmune disorders and mental health problems. Many cancers also involve such mutations. But finding which genetic changes cause disease remains difficult.

Potential Medical Applications

Natasha Latysheva, a DeepMind researcher, said the team sees AlphaGenome as a tool for understanding functional elements in the genome. The system could help scientists map which genetic sequences are essential for developing particular tissues like nerve and liver cells.

The tool might also support new gene therapies. Researchers could design DNA sequences to switch on certain genes in specific cell types but not others. Carl de Boer at the University of British Columbia noted that the system identifies whether mutations affect genome regulation and in what cell types. Drugs could then be developed to counteract these effects.

Scientific Reception

Some researchers have already started using AlphaGenome. Marc Mansour, a clinical professor at UCL, called it a step change in his work finding genetic drivers for cancer.

Gareth Hawkes at the University of Exeter said the non-coding genome makes up 98% of the 3 billion base pair genome. He added that having AlphaGenome make predictions about this region represents a big step forward. De Boer noted that achieving fully reliable predictions will require continued work from the scientific community.

Total
0
Shares
Previous Post
Editorial montage of Andy Jassy and Beth Galetti in neutral expressions, close-up portraits side by side with a bold Amazon smile logo centered between them, swirling blue AI circuitry and data nodes radiating outward, warm orange vs cool cyan color contrast, bright high-key lighting, tight framing with soft depth of field

Amazon cuts 16,000 jobs to speed up decisions in AI race

Next Post
Editorial close-up of Mark Zuckerberg centered against luminous futuristic data center aisles, a large Meta infinity logo softly glowing behind him, cool Meta blues contrasted with warm golden highlights, crisp neutral expression, high-brightness, medium-close framing, clean background.

Meta plans $135 billion spend to build super-smart AI

Related Posts